Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
LE Mansoor, L Lewis, CL Naicker… - Journal of the …, 2022 - Wiley Online Library
Introduction Oral tenofovir disoproxil fumarate/emtricitabine pre‐exposure prophylaxis
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
LE Mansoor, L Lewis, CL Naicker, I Harkoo… - Journal of the …, 2022 - europepmc.org
Methods This prospective cohort study (CAPRISA 082) was conducted at two sites (urban
and rural) in KwaZulu-Natal, between March 2016 and February 2018. HIV-negative …
and rural) in KwaZulu-Natal, between March 2016 and February 2018. HIV-negative …
Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
LE Mansoor, L Lewis, CL Naicker, I Harkoo, H Dawood… - 2022 - cabidigitallibrary.org
Introduction: Oral tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
LE Mansoor, L Lewis, CL Naicker… - Journal of the …, 2022 - search.proquest.com
Methods This prospective cohort study (CAPRISA 082) was conducted at two sites (urban
and rural) in KwaZulu‐Natal, between March 2016 and February 2018. HIV‐negative …
and rural) in KwaZulu‐Natal, between March 2016 and February 2018. HIV‐negative …
[HTML][HTML] Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
LE Mansoor, L Lewis, CL Naicker, I Harkoo… - Journal of the …, 2022 - ncbi.nlm.nih.gov
Methods This prospective cohort study (CAPRISA 082) was conducted at two sites (urban
and rural) in KwaZulu‐Natal, between March 2016 and February 2018. HIV‐negative …
and rural) in KwaZulu‐Natal, between March 2016 and February 2018. HIV‐negative …
Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa
LE Mansoor, L Lewis, CL Naicker… - Journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Oral tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
LE Mansoor, L Lewis, CL Naicker… - African Journal of …, 2022 - journals.lww.com
2.1 Study design The CAPRISA 082 study was a prospective cohort study conducted at two
Clinical Research Sites at urban (eThekwini) and rural (Vulindlela) in KwaZulu‐Natal, SA …
Clinical Research Sites at urban (eThekwini) and rural (Vulindlela) in KwaZulu‐Natal, SA …
[PDF][PDF] Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa
LE Mansoor, L Lewis, CL Naicker, I Harkoo, H Dawood… - 2022 - researchgate.net
Introduction: Oral tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …